Pancreatic Cancer Research

ResearcherGuangxi Medical UniversityActive in the last 2 years

Xin Zhou

Matched on ORCID iD 0000-0003-3152-5048; OpenAlex author ID A5000436077. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2019: 2 papers · 2020: 3 papers · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper

Papers 8

  1. Pancreatic cancer mortality trends attributable to high fasting blood sugar over the period 1990-2019 and projections up to 2040. Co-author DOI 10.3389/fendo.2024.1302436↗
  2. Prognostic value and potential molecular mechanism of the like-Sm gene family in early-stage pancreatic ductal adenocarcinoma. Co-author DOI 10.21037/tcr-20-3056↗
  3. UXT antisense RNA 1 sever as a novel prognostic long non-coding RNA in early stage pancreatic ductal adenocarcinoma patients after receiving pancreaticoduodene… Co-author DOI 10.7150/jca.46084↗
  4. Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential… Co-author DOI 10.1002/cam4.2699↗
  5. Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms. Co-author DOI 10.1186/s12876-020-01560-0↗
  6. Genome-wide RNA-sequencing dataset reveals the prognostic value and potential molecular mechanisms of lncRNA in non-homologous end joining pathway 1 in early s… Co-author DOI 10.7150/jca.39888↗
  7. Prognostic value of Kinesin-4 family genes mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy. Co-author DOI 10.1002/cam4.2524↗
  8. Clinical significance and prospective molecular mechanism of C‑C motif chemokine receptors in patients with early‑stage pancreatic ductal adenocarcinoma after … Co-author DOI 10.3892/or.2019.7277↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiwen Liao · 8 shared papers, 2019–2024 · strength 0.90
  2. Tao Peng · 8 shared papers, 2019–2024 · strength 0.90
  3. Xinping Ye · 7 shared papers, 2019–2021 · strength 0.69
  4. Chengkun Yang · 6 shared papers, 2019–2021 · strength 0.56
  5. Quan‐Fa Han · 4 shared papers, 2019–2020 · strength 0.34
  6. Junqi Liu · 3 shared papers, 2019–2020 · strength 0.25
  7. Zijun Chen · 2 shared papers, 2020–2021 · strength 0.22
  8. Yongguang Wei · 1 shared paper, 2024 · strength 0.21
  9. Wei Qin · 1 shared paper, 2024 · strength 0.21
  10. Liming Shang · 2 shared papers, 2019–2020 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.